White C, Ji S, Cai H, et al (2012) Therapeutic potential of vasoactive intestinal peptide and its receptors in neurological disorders
When it comes to reduction of weight-related issues like diabetes, heart disease risks and metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as nonalcoholic fatty liver disease (NAFLD), bariatric surgery far outpaces GLP-1s in reduction, and often removal, of these risks
In clinical terms, we say it drastically increases gastric motility , meaning your stomach empties its contents into the intestines at hyper-speed, making you feel completely empty and starved
But fullness, appetite, and metabolic signals can still feel unpredictable
Ribatti D, Tamma R, Annese T
What is the CJC-1295 and Ipamorelin blend